Group 1 - Heartflow, a provider of imaging and diagnostic software for coronary artery disease, has increased its IPO size to raise $292 million by offering 16.7 million shares at a price range of $17 to $18 per share [1][2] - The revised fundraising amount represents a 46% increase compared to the initial plan of raising funds through 12.5 million shares priced between $15 and $17 [1] - As of March 31, 2025, Heartflow's intelligent platform has provided CAD assessment services to over 400,000 patients, with 132,000 cases serviced in 2024 alone [1] Group 2 - Founded in 2007, Heartflow achieved revenue of $136 million for the fiscal year ending March 2025 [2] - The company plans to list on NASDAQ under the ticker symbol "HTFL," with JPMorgan, Morgan Stanley, and Piper Sandler serving as joint bookrunners, and pricing is expected to occur during the week of August 4, 2025 [2]
心脏成像软件供应商Heartflow(HTFL.US)上调IPO发行规模 拟募资2.92亿美元
Zhi Tong Cai Jing·2025-08-07 07:05